Federated Hermes’s OncoSec Medical Incorporated ONCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-15
Closed -$1K 2367
2022
Q1
$1K Buy
15
+8
+114% +$169 ﹤0.01% 2164
2021
Q4
$1K Buy
+7
New +$237 ﹤0.01% 2192

Other funds holding ONCS

Federated Hermes's ONCS Position: Q2 2022 in Review

Federated Hermes sold out of OncoSec Medical Incorporated (ONCS) in Q2 2022, closing a stake of 15 shares — an estimated $1K sold.

Federated Hermes first reported a position in ONCS in Q4 2021 and held it in 2 quarters. The position peaked at $1K in Q1 2022. 25 funds tracked by Wall St. Rank hold ONCS as of Q2 2022.

  • Federated Hermes reported no remaining OncoSec Medical Incorporated position as of Q2 2022 after selling out during the quarter.
  • Federated Hermes sold 15 OncoSec Medical Incorporated shares in Q2 2022, an estimated $1K.
  • Federated Hermes first reported a position in OncoSec Medical Incorporated in Q4 2021 and held it in 2 quarters.
  • Federated Hermes's OncoSec Medical Incorporated position peaked at $1K in Q1 2022.
  • 25 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q2 2022.

Based on Federated Hermes's 13F filing for Q2 2022, filed 15 Aug 2022.